RALEIGH, NC, Feb 06, 2014 (Marketwired via COMTEX) -- DARA BioSciences, Inc. DARA -8.62% ("DARA" or the "Company"), an oncology supportive care specialty pharmaceutical company dedicated to providing healthcare professionals a synergistic portfolio of medicines to help cancer patients adhere to their therapy and manage side effects arising from their cancer treatments, announced that it is effecting a 1-for-5 reverse stock split of its issued and outstanding common stock which will be effective for trading purposes as of the commencement of trading on February 10, 2014. As of that date, each 5 shares of issued and outstanding common stock and equivalents will be converted into 1 share of common stock. In addition, at the market open on February 10, 2014, the common stock will trade under a new CUSIP number 23703P304 although the Company's ticker symbol, DARA, will remain unchanged.
www.marketwatch.com/story/...t-2014-02-06?reflink=MW_news_stmp
www.marketwatch.com/story/...t-2014-02-06?reflink=MW_news_stmp
Ablaufdatum Onshore kommt immer näher
Nordeling-Lang KZ SemperMM von 40 auf 0,44€ reduziert
Nordeling-Lang KZ SemperMM von 40 auf 0,44€ reduziert